IBM Research is planning a new project in association with the Melanoma Institute Australia to use its 'cognitive' or self-learning computing technology to analyse dermatological images of skin lesions to help identify specific clinical patterns in the early stages of melanoma.

The new research builds on an existing agreement IBM has with skin cancer clinic operator MoleMap that uses advanced visual analytics to analyse data sets such as images and text.